Athira Pharma CEO placed on leave after questions about her doctoral research, shares sink more than 30%

Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review “stemming from doctoral research Dr. Kawas conducted while at Washington State University.”